Infectious Diseases Self-Assessment Program (IDSAP) 2026 (L269072)
ACPE Numbers: Various – see listing below Release Date: May 15, 2026 Expiration Dates: May 14, 2027 Activity Type: Application-based CE Credits: 16.5 contact hours (BPS and ACPE) Activity Fee: $88 (ASHP member); $132 (non-member)
Activity Overview
This course is intended for board-certified pharmacists in need of recertification credit and is designed based on the content outline developed by Board of Pharmacy Specialties (BPS). The course consists of 8learning modules (see table below) and provides up to 16.5 contact hours of continuing pharmacy education and/or recertification credit.
Learners will be required to review the content and complete the associated online assessments. The learner must be able to correctly answer the questions based upon their interpretation of the content, as well as “baseline specialty specific knowledge and/or easily retrievable information.” For purposes of this course, “baseline specialty specific knowledge and/or easily retrievable information” is defined as product labeling and well-established standards of practice in the specialty practice.
These activities are part of the ACCP and ASHP professional development program for BCIDP recertification approved by the BPS.
The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as providers of continuing pharmacy education.
The target audience for IDSAP 2026 is pharmacotherapy specialists and advanced-level clinical pharmacists whose responsibilities may include providing care for individuals with or at risk for infectious diseases.
Board-certified pharmacists are eligible to receive up to 16.5contact hours of recertification credit for completing this course. To earn recertification credit, learners must review the course content and successfully complete the online assessments by the deadline.
ASHP provides an opportunity for remediation. Participants who are unsuccessful with the first assessment attempt may take a second assessment. The second assessment is included at no additional cost.
ACCP and ASHP are approved by BPS as a provider for the recertification of BCIDP.
Learning Activity
Passing Score
Credit Information
Chapter: Staphylococcus aureus
73%
2.5 Contact Hours
BPS: BCIDP ACPE: 0217-9999-26-088-H01-P
Chapter: Enterococcus
80%
2.5 Contact Hours
BPS: BCIDP ACPE: 0217-9999-26-089-H01-P
Chapter: Vancomycin Dosing
73%
2.0 Contact Hours
BPS: BCIDP ACPE: 0217-9999-26-090-H01-P
Recorded Webcast: Surgical Prophylaxis
67%
1.5 Contact Hours
BPS: BCIDP ACPE: 0217-9999-26-091-H01-P
Chapter: C. difficile Infection
87%
2.0 Contact Hours
BPS: BCIDP ACPE: 0217-9999-26-092-H01-P
Chapter: Diagnostic Stewardship
87%
2.5 Contact Hours
BPS: BCIDP ACPE: 0217-9999-26-093-H01-P
Case Series: Collaborations with Clinical Microbiology
67%
2.0 Contact Hours
BPS: BCIDP ACPE: 0217-9999-26-094-H04-P
Chapter: Antimicrobial Stewardship Opportunities at Transitions of Care
Apply diagnostic stewardship principles to optimize diagnostic testing and antibiotic use in clinical practice.
Evaluate available evidence on implementing diagnostic stewardship interventions.
Evaluate and respond to challenges in prioritizing, implementing, and evaluating diagnostic stewardship interventions.
Case Series: Collaborations with Clinical Microbiology ACPE: 0217-9999-26-094-H04-P
Analyze the benefits, limitations, and clinical applications of different antibiogram types to support antimicrobial stewardship and patient care decisions.
Design susceptibility testing or reporting interventions on the basis of patient or hospital challenges and opportunities.
Describe the steps for implementing rapid diagnostic tests and explain the general benefits of their use, including the role of collaboration between microbiology and stewardship teams.
Develop a collaborative plan to educate health care staff on infectious syndrome management, specimen collection best practices, test characteristics, and result interpretation.
Chapter: Antimicrobial Stewardship Opportunities at Transitions of Care ACPE: 0217-9999-26-095-H01-P
Identify different patient transitions through health care settings where opportunities for antimicrobial stewardship (AS) exist.
Evaluate the effect of AS interventions at transitions of care (TOC) on the antimicrobial use process.
Develop strategies for implementing AS interventions at TOC.
In accordance with our accreditor’s Standards of Integrity and Independence in Accredited Continuing Education, ACCP and ASHP requires that all individuals in control of content disclose all financial relationships with ineligible companies. An individual has a relevant financial relationship if they have had a financial relationship with an ineligible company in any dollar amount in the past 24 months and the educational content that the individual controls is related to the business lines or products of the ineligible company.
An ineligible company is any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The presence or absence of relevant financial relationships will be disclosed to the activity audience.
The following persons in control of this activity’s content have relevant financial relationships:
Consultancies:David Cluck (Astellas); Riley Williams II (VPR); W. Justin Moore (GSK, Inc.); Clara Ni (Maryland Societyof Health SystemPharmacy);Kelly R. Reveles(FerringPharmaceuticals); Kimberly C. Claeys(bioMérieux);David Ha(Paratek); Jessica L. Sobnosky(AbbVie, Shinogi,Alembic, AMGResearch [spouse orsignificant other])
Financial Relationship: Kimberly C. Claeys (bioMérieux)
Grants:Kelly R. Reveles (AstraZeneca); Kimberly C. Claeys (QLineadiagnostics)
Honoraria:Riley Williams II (VPR);Erin Weslander(MidwesternUniversity College ofPharmacy); Kimberly C. Claeys (bioMérieux); Jessica L. Sobnosky(AbbVie,Shionogi, Melinta[spouse or significantother])
Royalties: Clara Ni (Capstan Medical[family member])
ACCP Staff/Series Leaders
Consultancies: Elizabeth Dodds-Ashley (Biomerieux)
Grants: Alan Gross (AHRQ); Krutika Mediwala Hornback(Precedent Network – Marck Research Funding)
Royalties: Elizabeth Dodds-Ashley (UpToDate)
Honoraria: Alan Gross (APhA; PROCE); Krutika MediwalaHornback (Cepheid Diagnostics)
Nothing to disclose: Ed Alderman, Peter Burns, Joanna Gillette,Brent Paloutzian, Kimma Sheldon-Old, Keri Sims
Activities consist of educational materials, assessments, and activity evaluations. In order to receive continuing pharmacy education credit, learners must:
Complete the attestation statement
Review all content
Complete and pass the assessments
Complete the evaluations
Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.
